CCL2 secreted by oncogene-induced senescent hepatocytes can recruit CCR2+ immature myeloid cells and then inhibit the antitumor function of NK cells, thereby promoting HCC tumor growth (19). This evidence concerns the gene CCL2 and neoplasm.